| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/25/2010 | WO2010003046A3 Gabapentin enacarbil salts and processes for their preparation |
| 02/25/2010 | WO2010001258A3 Inhibition of tumour growth and metastases |
| 02/25/2010 | WO2010000763A3 Combinations comprising mglur modulators for the treatment of parkinson's disease |
| 02/25/2010 | WO2009158571A8 Heteroaryl compounds and uses thereof |
| 02/25/2010 | WO2009158446A3 Crystalline forms of ((((4-((5-(cyclopropylcarbamoyl)-2-methylphenyl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbonyl)(propyl)carbamoyl)oxy)methyl (4-(phosphonooxy)phenyl)acetate, method of preparation and use thereof |
| 02/25/2010 | WO2009156677A3 Novel anhydrous depigmenting compositions comprising a solubilized phenolic derivative |
| 02/25/2010 | WO2009155585A9 Dna-directed customization of analgesic compounds as a therapeutic modality |
| 02/25/2010 | WO2009152356A3 Compounds and compositions useful for the treatment of malaria |
| 02/25/2010 | WO2009152344A3 Combination therapy using phosphodiesterase inhibitors |
| 02/25/2010 | WO2009152041A3 Controlled release formulations of pramipexole |
| 02/25/2010 | WO2009151683A3 Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
| 02/25/2010 | WO2009151569A3 Beta adrenergic receptor agonists for the treatment of b-cell proliferative disorders |
| 02/25/2010 | WO2009149795A3 Heterocyclic cyclopropyl-substituted fxr binding compounds |
| 02/25/2010 | WO2009149058A3 Modified release niacin formulations |
| 02/25/2010 | WO2009149056A3 Combinations of niacin and an oxicam |
| 02/25/2010 | WO2009148659A3 Antimalarial quinolines and methods of use thereof |
| 02/25/2010 | WO2009148600A8 Deuterated lysine-based compounds |
| 02/25/2010 | WO2009146218A8 Compounds including an anti-inflammatory pharmacore and methods of use |
| 02/25/2010 | WO2009145816A3 Novel n-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents |
| 02/25/2010 | WO2009144550A3 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality |
| 02/25/2010 | WO2009143515A3 Treatment using continuous low dose application of sugar analogs |
| 02/25/2010 | WO2009143365A3 Compositions and methods of treatment using modulators of motoneuron diseases |
| 02/25/2010 | WO2009142988A3 Chitin micro-particles as an adjuvant |
| 02/25/2010 | WO2009142428A3 Pharmaceutical composition for the treatment of premature ejaculation |
| 02/25/2010 | WO2009140621A3 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof |
| 02/25/2010 | WO2009140421A3 Polymeric carrier |
| 02/25/2010 | WO2009140101A3 Imidazopyridine compounds useful as mmp-13 inhibitors |
| 02/25/2010 | WO2009139901A3 Methods and compositions for improving cognitive function |
| 02/25/2010 | WO2009138843A9 Glycosaminoglycan oral use and compositions |
| 02/25/2010 | WO2009133455A3 Pharmaceutical composition of clodipogrel |
| 02/25/2010 | WO2009129494A4 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation |
| 02/25/2010 | WO2009129460A3 Clonidine formulations in a biodegradable polymer carrier |
| 02/25/2010 | WO2009124086A3 Antibacterial drug for treatment of staphylococcus aureus and other gram-positive bacterial infections |
| 02/25/2010 | WO2009115651A3 N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof |
| 02/25/2010 | WO2009111169A3 Compositions comprising pkc-delta modulators and methods for ocular neuroprotection |
| 02/25/2010 | WO2009106752A3 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereof and therapeutic application thereof |
| 02/25/2010 | WO2009106751A3 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2- a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 02/25/2010 | WO2009106750A3 Derivatives of 6-heterocyclic-imidazo[l,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 02/25/2010 | WO2009101216A3 Omega-cyclohexylalkan-1-oles and use thereof as antimicrobial actives to combat body odor |
| 02/25/2010 | WO2009091433A3 Spiro and dispiro 1,2,4-trioxolane antimalarials |
| 02/25/2010 | WO2009087242A3 Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent |
| 02/25/2010 | WO2009087238A9 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 02/25/2010 | WO2009086076A3 Particles for injection and processes for forming the same |
| 02/25/2010 | WO2009077736A4 A medicament comprising a parasympathetic agonist and a sympathetic antagonist or a sympathetic agonist |
| 02/25/2010 | WO2009077471A3 Azolylmethyloxiranes, use thereof and agents containing the same |
| 02/25/2010 | WO2009077443A3 Azolylmethyloxiranes, use thereof and agents containing the same |
| 02/25/2010 | WO2009077147A3 Pharmaceutical compositions |
| 02/25/2010 | WO2009034537A3 Cosmetic composition comprising hydroxymethionine and 3-aminopropanesulfonic acid |
| 02/25/2010 | WO2009031006A3 Antiviral topical formulations in the form of a bio-adhesive gel |
| 02/25/2010 | WO2009013621A3 Antibodies and sirna against growth hormone, prolactin and proliferin for use in the treatment of tumors and endometriosis |
| 02/25/2010 | WO2009008694A8 Pharmaceutical composition comprising the combination of an anti-depressive agent and an ansiolytic agent for control and treatment of depressive disorders |
| 02/25/2010 | WO2009000286A8 Improved pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof |
| 02/25/2010 | WO2008149346A3 Enhanced sensitivity polymerase chain reactions |
| 02/25/2010 | WO2008149345A3 Tri-aryl compounds and compositions comprising the same |
| 02/25/2010 | WO2008146283A3 Palonosetron salts with preparation and purification thereof |
| 02/25/2010 | WO2008144347A8 Combinations comprising a fluoroquinolone for treating, reducing, ameliorating, or preventing infections |
| 02/25/2010 | WO2008126088A3 Anti-pyretic vasodilators |
| 02/25/2010 | WO2008126085A3 Method for treating bone marrow disorders |
| 02/25/2010 | WO2008126076A3 Low-dose mometasone formulations |
| 02/25/2010 | WO2004092124A8 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 02/25/2010 | WO2002068414A8 Analogs of thalidomide as potential angiogenesis inhibitors |
| 02/25/2010 | US20100050281 Identification of Genes and Their Products Which Promote Hybrid Vigour or Hybrid Debility and Uses Thereof |
| 02/25/2010 | US20100048763 Bone cement compositions having fiber-reinforcement and/or increased flowability |
| 02/25/2010 | US20100048732 Method of mediating Airway Smooth Muscle Construction Due to Airway Irritation |
| 02/25/2010 | US20100048731 Hydroxylated Long-Chain Resveratrol Derivatives Useful as Neurotrophic Agents |
| 02/25/2010 | US20100048730 Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents |
| 02/25/2010 | US20100048729 Composition based on xanthoxyline and its use in cosmetic |
| 02/25/2010 | US20100048728 Polycyclic dianthraquinones as inhibitors of inflammatory cytokines |
| 02/25/2010 | US20100048727 Perfluoroketone compounds and uses thereof |
| 02/25/2010 | US20100048726 Memantine For The Treatment Of Mild And Mild To Moderate Alzheimer's Disease |
| 02/25/2010 | US20100048725 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
| 02/25/2010 | US20100048723 Compositions and Methods for Preventing or Treating Obesity In Animals |
| 02/25/2010 | US20100048722 FORMATION OF ACCUMBENS GluR2-LACKING AMPA RECEPTORS MEDIATES INCUBATION OF COCAINE CRAVING |
| 02/25/2010 | US20100048721 Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders |
| 02/25/2010 | US20100048720 Process for the Preparation of and Crystalline Forms of Optical Enantiomers of Modafinil |
| 02/25/2010 | US20100048719 Process for the Preparation of and Crystalline Forms of Optical Enantiomers of Modafinil |
| 02/25/2010 | US20100048718 Process for the Preparation of and Crystalline Forms of Optical Enantiomers of Modafinil |
| 02/25/2010 | US20100048717 Cathepsin b inhibitors |
| 02/25/2010 | US20100048716 Crystalline forms of aliskiren hemifumarate |
| 02/25/2010 | US20100048714 Methods and Compositions Related to Inhibition of Ceramide Synthesis |
| 02/25/2010 | US20100048713 Compounds acting on the serotonin transporter |
| 02/25/2010 | US20100048712 Acyclic Sulfamide Derivatives |
| 02/25/2010 | US20100048711 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 02/25/2010 | US20100048710 Methods and Compositions for Modulating Muscle Fat in Livestock |
| 02/25/2010 | US20100048709 Treatment of Prostate Cancer with DDC Inhibitor |
| 02/25/2010 | US20100048708 Tamibarotene capsule preparation |
| 02/25/2010 | US20100048706 Ethoxylated and/or Hydrogenated Oil Adduct |
| 02/25/2010 | US20100048705 Methods of treating and preventing neovascularization with omega-3 polyunsaturated fatty acids |
| 02/25/2010 | US20100048704 Pharmaceutical and nutraceutical products comprising vitamin k2 |
| 02/25/2010 | US20100048703 Hair care product |
| 02/25/2010 | US20100048702 Prevention of neutrophil recruitment |
| 02/25/2010 | US20100048701 Amide compound and use thereof for controlling plant diseases |
| 02/25/2010 | US20100048698 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 02/25/2010 | US20100048697 Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions |
| 02/25/2010 | US20100048695 Anti-fatigue agent |
| 02/25/2010 | US20100048694 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality |
| 02/25/2010 | US20100048693 Treatment of COPD |
| 02/25/2010 | US20100048692 Naphthofuranone Derivatives as Specific Inhibitors of Thymidylate Synthases |
| 02/25/2010 | US20100048691 Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
| 02/25/2010 | US20100048690 Antitumoral dihydropyran-2-one compounds |